Go Deep
Metagenomi Therapeutics, Inc.
Metagenomi Therapeutics, Inc. Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 23,191 | -0.4 | 0.29 | 0.34 | 81.77 |
| Oct 2026 | 23,213 | -0.4 | 0.28 | 0.34 | 80.26 |
| Oct 2026 | 23,139 | -0.3 | 0.26 | 0.34 | 74.26 |
| Oct 2026 | 23,093 | -0.3 | 0.27 | 0.34 | 76.97 |
| Oct 2026 | 23,056 | -0.3 | 0.28 | 0.34 | 78.82 |
| Oct 2026 | 22,995 | -0.3 | 0.28 | 0.34 | 78.39 |
| Oct 2026 | 22,928 | -0.3 | 0.27 | 0.34 | 77.04 |
Metagenomi Therapeutics, Inc. Quarterly Results
Quarterly data isn't available for this company right now.
Metagenomi Therapeutics, Inc. Revenue & Profit
Annual financial data isn't available for this company right now.
Metagenomi Therapeutics, Inc. Balance Sheet
Balance sheet data isn't available for this company right now.
Owes vs Owns
Metagenomi Therapeutics, Inc. owed $0.35 for every $1 it owned in Jun 2026, down from $1.18 in Dec 2022.
| Period | Jun 2026 | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|---|
| Owes vs Owns | 0.35× | 0.28× | 0.28× | 1.37× | 1.18× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Metagenomi Therapeutics, Inc. Cash Flow
Cash flow data isn't available for this company right now.